Big da­ta meets Big Phar­ma: Pfiz­er buys re­al-time pa­tient re­sults in col­lab­o­ra­tion with Tru­ve­ta

Ter­ry My­er­son led one of the most prof­itable arms of Mi­crosoft dur­ing his 21-year tenure there, hav­ing a hand in the de­vel­op­ment of Win­dows and Xbox soft­ware. But My­er­son start­ed out as a pre-med stu­dent be­fore all of that and turned to life sci­ences in­vest­ing af­ter his stint at Mi­crosoft end­ed in 2018.

My­er­son is now the CEO of Tru­ve­ta, a for-prof­it da­ta ven­ture backed by 20 US health sys­tems, which was seed­ed from a project My­er­son was work­ing on in the midst of the pan­dem­ic with Prov­i­dence, a hos­pi­tal sys­tem on the West Coast. Tru­ve­ta an­nounced to­day a part­ner­ship with Pfiz­er, one that gives the Big Phar­ma ac­cess to re­al-time da­ta on some 50 mil­lion de-iden­ti­fied pa­tients.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER